Knight Therapeutics increases March 01, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
Knight Therapeutics Inc. (TSX:GUD), Canada's 2nd largest Drug manufacturers company by market cap, has increased 5.0c (0.5%) from its last trading session of February 28 to close at CAD10.77. Compared with the S&P/TSX 60 Index which rose 11.1 points (1.2%) in the day, the relative price change was -0.8%. The volume was 0.5 times the average daily trading volume of 257,137 shares.
APPOINTMENT OF DIRECTOR
The company appointed Sarit Assouline as direc...